On the recordApril 15, 2013
Our drug supply needs to have FDA oversight and drug compounders shouldn't get to create--to evade regulation by the agency.
Source
congress.govEditor's note · Context
Schakowsky emphasizes the necessity of FDA oversight for drug compounders.
Share & report
More from Janice Schakowsky
Jun 13, 2023
Mr. Chairman, I will say that there were a lot of things said that are really misinformation. No one is going to lose their gas stoves. This is not a plot to take that away. I certainly encourage everyone to vote against this so that we…
Sep 18, 2023
Thank for your attention to this important matter. We respectfully request that you provide a response within 30 days detailing actions the agency will take to strengthen the SGO.
Oct 18, 2023
I agree with my dear friend, John Yarmuth, that when we have a functioning Congress...
Jul 18, 2023
Mr. Speaker, had I been present, I would have voted ``nay'' on rollcall No. 333 and ``nay'' on rollcall No. 334. ____________________
Other voices in this conversation
